How brands can tap into wellness – lessons from influencers
Bio Pharma Dive
NOVEMBER 21, 2022
Our latest research uncovers new insights on how brands can truly close the wellness gap and grow within their industry sectors.
This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Bio Pharma Dive
NOVEMBER 21, 2022
Our latest research uncovers new insights on how brands can truly close the wellness gap and grow within their industry sectors.
Bio Pharma Dive
DECEMBER 11, 2023
Editas had the tall task Monday of convincing ASH attendees its gene therapy for sickle cell disease could improve on Casgevy and Lyfgenia.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
FEBRUARY 28, 2022
Self-care and the resulting increased use of over-the-counter (OTC) medications is a growing global trend.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 22, 2022
Drug manufacturers have hailed the Drugs (Eighth Amendment) Rules, 2022 mandating barcode or quick response (QR) code on the label of top 300 brands of formulations from August 1, 2023, saying that QR codes will help identify misbranded or counterfeit medicines as well as recall the products if its quality gets compromised during manufacturing.
pharmaphorum
JUNE 17, 2024
Learn how to upscale your brand strategy with new and innovative ways of planning. Discover effective brand planning strategies to take your brand to the next level.
Bio Pharma Dive
DECEMBER 2, 2024
The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.
Pharmaceutical Technology
JANUARY 22, 2024
An analysis of GlobalData’s analyst consensus sales and forecast database reveals that three out of 12 novel oncology brands that launched globally from November 2022 to December 2023 have the potential to reach blockbuster sales.
pharmaphorum
JUNE 28, 2024
Amazon’s strategy in telehealth has coalesced around a pay-per-visit and subscription-based model under a new brand – Amazon One Medical.
Drug Patent Watch
JUNE 18, 2024
Branded generics are generic drugs that are marketed under a brand name by the manufacturer. These products contain the same active ingredients as their brand-name counterparts but are typically sold at a lower price point.
Bio Pharma Dive
MARCH 29, 2021
Learn how three pharma brands used data to validate and adjust their promotional spend in 2020.
pharmaphorum
JANUARY 17, 2024
New technologies have revolutionised brand planning and strategy development, making it easier than ever to create and execute effective brand plans. Explore how these technologies simplify the brand planning process and maximise success.
Bio Pharma Dive
NOVEMBER 12, 2021
The industry giant and mainstay of corporate America will separate its consumer health business from its drug and medical device units, which will retain the J&J brand.
pharmaphorum
FEBRUARY 6, 2024
Daniel Kohlstaedt, managing director at PurpleLeaf Strategy, discusses how new technologies can help pharmaceutical leaders plan for success during their upcoming brand planning cycle.
Bio Pharma Dive
MAY 13, 2022
Tirzepatide, now branded as Mounjaro, helped improve blood sugar control in testing and has been shown to have powerful weight loss effects as well, making it one of the most closely watched drugs in Lilly's pipeline.
Bio Pharma Dive
NOVEMBER 11, 2024
Developer Autolus set a list price of $525,000 for its new cell therapy, which it will sell for a type of leukemia under the brand name Aucatzyl.
Fierce Pharma
FEBRUARY 2, 2024
The strategy includes 11 key growth brands and a continued emphasis on business development.
Bio Pharma Dive
OCTOBER 17, 2024
The French drugmaker will invest 300 million euros into a new entity that will develop lead isotope-based therapies for cancer under the Orano Med brand.
Bio Pharma Dive
NOVEMBER 8, 2023
The pharmaceutical company will sell the GLP-1 drug, branded as Zepbound, at a list price about 20% lower than Novo Nordisk's competing drug Wegovy.
World of DTC Marketing
AUGUST 9, 2020
This team of consultants would ideally be made up of people who not only have expertise in digital marketing but who also can ensure that a brand team’s digital strategy is aligned with online health seekers. Right now a lot of brands, both inside and outside of pharma, are flying blind when it comes to digital.
Pharmaceutical Technology
JULY 2, 2024
Leqembi will now face a challenger as donanemab enters the market under the brand name Kisunla.
Bio Pharma Dive
MARCH 14, 2023
Responding to policy changes and pressure over high drug costs, the pharma is reducing the sticker price of four branded diabetes medicines by up to 75%.
STAT News
APRIL 4, 2023
Until now, the company has focused on selling generic versions of brand-name medicines. But in a tweet yesterday, the upstart announced that it is selling the Invokana and Invokamet diabetes drugs from Janssen, a unit at Johnson & Johnson.
World of DTC Marketing
JULY 30, 2021
Ensuring you have hired the right one is essential to your brand’s success on both the HCP and consumers’ sides. Many CPG brands are bringing their digital marketing and media buying in-house to reduce costs and ensure that the digital strategies are aligned with key brand insights. This was a huge benefit for us.
Bio Pharma Dive
APRIL 21, 2022
List prices for branded medicines rose by nearly 5% last year, according to IQVIA, a figure that fell to 1% after accounting for rebates and discounts.
Fierce Pharma
JULY 16, 2024
With several launches underway and partnerships driving sales growth, Sobi is gaining momentum in its quest to become a force in hematology. | The Swedish drugmaker reported 13% sales growth in its hematology portfolio, which includes brands such as Doptelet, Vonjo and Apellis-partnered Empaveli (or Aspaveli in Europe, which is one of Sobi's (..)
Bio Pharma Dive
OCTOBER 27, 2020
The startup, which aims to develop lower-cost alternatives to branded medicines, has licensed two drugs from CStone Pharmaceuticals in a deal that could signal a coming price war in cancer immunotherapy.
Bio Pharma Dive
AUGUST 5, 2024
For years, many manufacturers have assumed that pre-market physician education was not strictly necessary unless their brand was the first to market or had a novel mechanism of action. With the advent of precision medicine, however, ongoing disease state education has become increasingly critical.
Intouch Solutions
MARCH 13, 2024
Our team is on the ground at SXSW 2024, and as we navigate through the bustling streets of downtown Austin, Texas — where the magic of immersive brand experiences dress the streets — we can’t help but feel the pulse of innovation surrounding us. Contact us to learn how you can ensure your brand is staying ahead of the curve.
Fierce Pharma
SEPTEMBER 14, 2023
J&J is uniting its medtech and pharmaceutical arms so that they will be “more connected to the Johnson & Johnson brand," the company said. Alongside a new logo reveal Thursday, Johnson & Johnson unveiled some major changes to its corporate persona. |
Pharmaceutical Technology
SEPTEMBER 6, 2023
Sandoz, the generics division of Novartis, has underperformed in recent years, but the spin-off may not settle investors.
Drug Patent Watch
DECEMBER 12, 2024
Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. Branded drugs, developed through extensive research and clinical trials, often enjoy patent protection for a limited period.
AuroBlog - Aurous Healthcare Clinical Trials blog
SEPTEMBER 16, 2024
Sold under the brand name Ubrelvy, ubrogepant is already used to treat migraines, but researchers in the US wanted to […]
AuroBlog - Aurous Healthcare Clinical Trials blog
OCTOBER 15, 2024
(Abdullah Durmaz/Getty Images) In just a few years, brand-name injectable drugs such as Ozempic, Wegovy, Mounjaro and Zepbound have rocketed to fame as billion-dollar annual sellers for weight loss as well as to control blood sugar levels and reduce the risk of heart disease.
Pharma Mirror
MAY 19, 2021
From 14th February 2021, Rashedi Hassan focuses his responsibility on developing extensive marketing and sales plan to strengthen the Telstar brand position in the local pharmaceutical market and to promote the presence and distribution of Telstar branded Life Sciences service & product solutions in the region, particularly in the field of engineering (..)
Bio Pharma Dive
AUGUST 10, 2023
The drug, which will be sold under the brand name Talvey, is now cleared by the FDA to treat multiple myeloma, a blood cancer that J&J has identified as a research priority.
Bio Pharma Dive
MAY 25, 2022
The new initiative commits Pfizer to supplying current and future branded medicines at lower cost to 45 countries. The pharma has been criticized for not doing enough to make its COVID-19 vaccine and pill available globally.
AuroBlog - Aurous Healthcare Clinical Trials blog
NOVEMBER 17, 2022
Acetaminophen, also known as paracetamol and sold widely under the brand names Tylenol and Panadol, also increases risk-taking, according to a study from 2020 […]. One of the most consumed drugs in the US – and the most commonly taken analgesic worldwide – could do a lot more than simply take the edge off your headache.
Pharmaceutical Technology
JANUARY 30, 2023
on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. The forecast branded NHS drug sales growth figure for 2023 was adjusted to 5.63%. The UK government’s decision to set an unprecedented payback rate of 26.5%
World of DTC Marketing
JANUARY 4, 2021
The age of social media has proved that people like to share experiences around brands. 7even : Every brand team should have an integrated digital marketing person. They should not rely on a “digital team” who meets with the brand to launch digital initiatives. 10en : Expect the media to be hostile towards pharma.
Bio Pharma Dive
APRIL 26, 2024
Prescription volume erosion is tracking with company forecasts, executives claimed, even as more insurers could exclude the branded drug.
World of DTC Marketing
AUGUST 17, 2021
It should be because they are a good fit with your brand team and can take your digital marketing to the next level while ensuring that everything they do is best in class. ” When I hire an agency, I want two things: seamlessly integrating within the brand team and quick turnarounds on minor work and proposals.
pharmaphorum
APRIL 30, 2024
California will start selling its own generic of overdose reversal agent naloxone in another example of the use of government-level purchasing power to reduce drug prices
World of DTC Marketing
APRIL 19, 2022
There are three essential elements of any good marketing plan: brand objective, Strategy, and tactics. Brand managers usually spend a lot of meetings getting approval for product launches, but that could be a huge mistake. Traffic to your website does not correspond to brand objectives and should not be used as a KPI.
Fierce Pharma
FEBRUARY 13, 2024
While Biogen’s financials are in rough shape now, the company’s CEO, Chris Viebacher, sees reason to be optimistic about the future.
Expert insights. Personalized for you.
We have resent the email to
Are you sure you want to cancel your subscriptions?
Let's personalize your content